Fatty Liver Study in Patients With Type II Diabetes

NCT02365233 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped IRB withheld the data due to inadequate supporting documentation

Conditions

Type II Diabetes
Nonalcoholic Fatty Liver

Interventions

DRUG: DPP4 inhibitor
DRUG: Pioglitazone
DRUG: Lantus insulin

Sponsor

The University of Texas Medical Branch, Galveston